Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence

Abdullaev, 2010, Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse, Behavioural Brain Research, 215, 45, 10.1016/j.bbr.2010.06.023 CNS Vital Signs, LLC Fried, 2005, Neurocognitive consequences of marihuana— A comparison with pre-drug performance, Neurotoxicology and Teratology, 27, 231, 10.1016/j.ntt.2004.11.003 Gray, 2012, A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents, The American Journal of Psychiatry, 169, 805, 10.1176/appi.ajp.2012.12010055 Gualtieri, 2006, Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs, Archives of Clinical Neuropsychology, 21, 623, 10.1016/j.acn.2006.05.007 Hanson, 2010, Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence, Addictive Behaviors, 35, 970, 10.1016/j.addbeh.2010.06.012 Heishman, 2009, Reliability and validity of a short form of the marijuana craving questionnaire, Drug and Alcohol Dependence, 102, 35, 10.1016/j.drugalcdep.2008.12.010 Johnston, 2014 Medina, 2007, Neuropsychological functioning in adolescent marijuana users: Subtle deficits detectable after a month of abstinence, Journal of the International Neuropsychological Society, 13, 807, 10.1017/S1355617707071032 Loring, 2012, Acute lorazepam effects on neurocognitive performance, Epilepsy & Behavior, 25, 329, 10.1016/j.yebeh.2012.08.019 Meier, 2012, Persistent cannabis users show neuropsychological decline from childhood to midlife, Proceedings of the National Academy of Sciences, 209, E2657, 10.1073/pnas.1206820109 Patterson, 1971, Recovery of inter-block information when block sizes are unequal, Biometrika, 58, 545, 10.1093/biomet/58.3.545 Randolph, 2013, Cannabis and cognitive systems in adolescents, Adolescent Psychiatry, 3, 135, 10.2174/2210676611303020004 Roten, 2013, Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial, Addictive Behaviors, 38, 1788, 10.1016/j.addbeh.2012.11.003 SAS® 9.3. Cary, NC: SAS Institute. Inc. 2011.